Michael F. Roman - 30 Jun 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Michael F. Roman by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
30 Jun 2021
Net transactions value
+$21,911
Form type
4
Filing time
02 Jul 2021, 17:05:03 UTC
Next filing
04 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Stock Equivalent Units Award $21,911 +189 $115.93 189 30 Jun 2021 Common Shares 189 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.